Stay updated on ATB200 Safety & PK Clinical Trial
Sign up to get notified when there's something new on the ATB200 Safety & PK Clinical Trial page.

Latest updates to the ATB200 Safety & PK Clinical Trial page
- ChecktodayChange DetectedThe page now displays a Results Posted date (2025-10-23), replacing the prior Results Submitted status. It also updates the study design details (Stages 1–4) and eligibility criteria to reflect current trial information.SummaryDifference6%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed mention of v3.1.0.SummaryDifference4%

- Check29 days agoChange DetectedThe page updates the disease name capitalization and increases the revision version from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded a new ahead-of-print citation with full author names and details; updated the page from v3.0.1 to v3.0.2, and removed the Back to Top element.SummaryDifference3%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with significant publications related to the study, including details about cipaglucosidase alfa and its efficacy in treating Pompe disease. Additionally, several outdated terms and categories have been removed.SummaryDifference11%

Stay in the know with updates to ATB200 Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATB200 Safety & PK Clinical Trial page.